• TRM (USD/COP)COP 3,461.92 +1.37% +COP 46.82Colombia's official exchange rate (Financial Superintendence), valid Nov 21 to Nov 23
  • EuroCOP 3,804.64 +1.37% +COP 51.45Reference: TRM crossed with the European Central Bank rate of Nov 20; not the market quote
  • Mexican pesoCOP 181.56 +1.37% +COP 2.45Reference: TRM crossed with the European Central Bank rate of Nov 20; not the market quote

Pfizer raises full-year guidance and bets on cancer and weight-loss drugs

FinanceInternationalBarron's10 s readAI summary
Image: Barron's

Pfizer raised its full-year guidance after reporting its latest quarterly results, driven by growth in its non-Covid products and acquired medicines. The company frames this as its second act after the pandemic, with bets on oncology and weight-loss drugs.

Read the full story at Barron's

IASummary generated by artificial intelligence from a story by Barron's. It may contain errors: the original source prevails.

More flashes